Jul 7, 2011
By:
Rich Whitworth
The European Medicines Agency has responded positively to a new directive published in the Official Journal of the European Union addressing concerns over increases in falsified medicines in the supply chain.
|
|
High demand could lead to innovation in controlled-release injectables.
Jul 2, 2011
By:
Erik Greb, Rich Whitworth
High demand could lead to innovation in controlled-release injectables.
|
Jul 1, 2011
By:
Rich Whitworth
One of the perks of my job is that I can travel to previously unvisited cities. This month, I was lucky enough to be in Switzerland.
|
Jun 30, 2011
By:
Rich Whitworth
The European Medicines Agency (EMA) has held a second forum regarding the implementation of new pharmacovigilance legislation, which gave stakeholders the opportunity to discuss their expectations on various aspects of the new legislation's execution.
|
Jun 2, 2011
By:
Rich Whitworth
An independent report released by the European Medicines Agency highlighted a number of recommendations to aid the agency in its communication of the benefits and risks of medicines.
|
Jun 1, 2011
By:
Rich Whitworth
It was a mixed crowd hosted by Dusseldorf in the middle of May.
|
May 5, 2011
By:
Rich Whitworth
Israel-based Teva Industries seals deal to acquire Cephalon for $6.8 billion.
|
May 3, 2011
By:
Rich Whitworth
As I strolled through Times Square, famous brand coffee cup in hand, towards the Jacob K. Javits Convention Center in New York, my thoughts were entirely focused on Interphex.
|
Apr 28, 2011
By:
Rich Whitworth
Warner Chilcott announced in a press release on Apr. 18, 2011, its intentions restructure, placing 500 Western European jobs on the line.
|
|
